Topic Archives: psoriasis

Comments

  • Gr8Full!

    $KALTF > Kalytera to Enter Medical Cannabis Market With Focus on Treatment of Psoriasis and Menstrual Cramps Websit...

  • Avatar

    $KDMN $Question to all Hi all. EDIT: The formatting of this comment is refusing to settle correctly. I am not a fa...

  • Avatar

    $DERM LONG Dermira (DERM 26.53) target lowered to $39 from $43 at Mizuho. Firm notes update their model post-3Q:17, ...

  • SoGiAm

    AbbVie's stock climbs after positive late-stage trial results of psoriasis treatment Today 8:12 AM ET (MarketWatch) Sh...

  • Avatar

    #vanillin Thanks for this Frank. Who da thunk skin rubbing with artificial vanilla, real vanilla won’t do, would red...

  • Dr. KSS MD PhD

    Oh, believe me, we don't differ. If the call were mine, I would never chase psoriasis as an indication. My impetus in th...

  • Avatar

    Very interesting insight, Doc. Much appreciated. I do have one point where we differ and thought I’d voice my thoughts...

  • Avatar

    $AUPH Doc, I was wondering about psoriasis as well. I know the company they combined with named Isotechnica went all t...

  • Dr. KSS MD PhD

    Agree with above. I wanted to add that in his presentation, Glickman noted it is entirely possible that Aurinia could be...

  • Avatar

    $IPIX np. Dr KSS, do you think their Prurisol still has a chance? I've a sister with Psoriasis.......

  • Dr. KSS MD PhD

    Joe: As I recall, from last time I looked in on $CTIX, they are still trialing brilacidin for oral mucositis in oncology...

  • Avatar

    $AUPH long Some historical DD. Looking at clinical trials.gov, before 2012, there were trials evaluating voclosporin,...

  • Dr. KSS MD PhD

    Yes, we've discussed Galectin at length in the past. Early on I gave them the intellectual benefit of doubt and did vast...

  • Avatar

    I was interested on Dr. KSS or others thoughts on GALT , Galectin Therapeutics , it pipe line is targeting galectin usin...

  • Avatar

    Re: $AUPH jumboh, I'll refer you to two comments made by Dr. KSS in this post; hopefully he can elaborate more abo...

  • Avatar

    $SNGX: I want to cover this rare diseases company, Solginex which is currently trading in the vicinity of 52-week lows w...

  • Avatar

    I would challenge the assertion that Humira is the top selling drug world wide. REMICADE was the first patentable monoc...

  • Avatar

    Here is Dr KSS comments on psoriasis, etc.... Author: Dr. KSS MD PhD Comment: Hi: the first thing I'd suggest i...

  • SoGiAm

    wmrw, shall continue looking for you.... re: psoriasis #NASH... remember several #ZKSS posts on the subject over the y...

  • Avatar

    Hi, This paper, published in 2015, was the first major publication linking psoriasis with non-alcoholic fatty liver. Cou...

  • SoGiAm

    wmrw, type in 'psoriasis' in the little box labeled Comment Search just below and right of where you type in a post and...

  • Avatar

    Hi Jack, I have been searching for about an hour and I can't find the Dr. KSS post you are referring to here about Psor...

  • Avatar

    Dr. Kiss, I read with great interest the post about the link between psoriasis and NAFLD. Of late, I've been gaining...

  • SoGiAm

    #Psoriasis May Be Associated with #LiverDisease, Research Shows. #Hepatology http://ow.ly/cJ5q3089iDs $GNFT #NASH https...

  • Avatar

    $DERM np; Final CIMZIA® (certolizumab pegol) Phase 3 Trial Meets Primary Efficacy Endpoint in Patients with Moderate-to...

  • SoGiAm

    $OWCP np - Copied from: There is a new comment on: What's the pre-election "Secret '$50 Marijuana Stock Blueprint'" Pit...

  • Avatar

    OWCP -- OWC Pharmaceutical Research Corp. is engaged in the business, through its wholly-owned Israeli subsidiary, One W...

  • SoGiAm

    $PHMD Investor Information: Corporate Profile PhotoMedex is a global skin health company providing integrated diseas...

  • Avatar

    $ctix - I have a bit of CTIX - comparing with cempra seems like a real bargain about 1/3 the mkt cap and has Brilacidin ...

  • SoGiAm

    $CTIX update We would like to inform shareholders that clinicaltrials.gov has updated its website to include our Phase 2...

  • achandra13

    $CTIX Cellceutix Begins Phase 2b Clinical Trial of Oral Prurisol in Moderate-to-Severe Chronic Plaque Psoriasis ht...

  • Dr. KSS MD PhD

    Question of the Week: Aurinia $AUPH is developing voclosporin, a calcineurin inhibitor, for lupus nephritis. Which on...

  • Avatar

    As a person with psoriasis, a virtually incurable condition, there is one thing I have come to understand: What is good...

  • Avatar

    $GNFT : and here is the press release in English: http://www.genfit.com/wp-content/uploads/2016/09/160923_PR_GENFIT-RORg...

  • SoGiAm

    $CTIX conferences Sept 9 and 19th Cellceutix Corporation to Present at Upcoming Conferences BEVERLY, MA--(Marketwire...

  • Dr. KSS MD PhD

    Hi Dan: The Fibroscan method is a non-invasive method of assessing fibrosis, but has its limitations. In the case of the...

  • SoGiAm

    $CTIX: Cellceutix to Initiate Phase 2b Trial of Prurisol for Chronic Plaque Psoriasis - Yahoo Finance via Helen https://...

  • Dr. KSS MD PhD

    Thanks Anshuman. Ah, the corporate kabuki....the glissando of insincerity.....the half-executed pirouettes: they extend ...

  • achandra13

    $CTIX Doc thought you'll find this useful from the latest press release. I think CTIX has a good drug on hand with Pu...

  • Dr. KSS MD PhD

    This event does, to a significant degree, rekindle my interest in $CTIX. They seem to be making no excuses here, and tho...

  • achandra13

    Re: $CTIX Cellceutix phase2 trial of prurisol for mild to moderate psoriasis meets primary endpoint http://cellceuti...

  • Avatar

    $CCXI Reading thru the full data set its obvious; CCX168 is a stellar drug. I beats standard of care on every measure...

  • Avatar

    $CCXI Chemocentryx are on a manic roll! Now they take on psoriasis. --- "ChemoCentryx Announces Data Presentation o...

  • sogiam

    $CTIX is indulging in funny compounds. Prurisol actually abacavir that approved for HIV/AIDS. https://en.wikipedia.org...

  • jer_vic

    $CTIX Cellceutix Concludes Last Patient Visit in Phase 2 FDA Trial of Oral Dosed Prurisol in Patients With Mild-to-Mode...

  • Avatar

    $ABBV Again from ETF Channel, AbbVie is a research-based biopharmaceutical company that develops and markets therapies ...

  • sogiam

    XNPT- XenoPort, Inc. (NASDAQ: XNPT) shares rose 8.32 percent to $7.29 in pre-market trading after the company reported p...

  • DBMD

    I couldn't figure out why Robert Frost was buying so much OPK. I can't get excited about an anti emetic drug. He has bou...

  • Avatar

    Re: Prednisone side effects. I had a coworker for many years, started as a bright young lad, on the tall side, slender,...

  • Avatar

    I might be wrong here, but I think I can shed a little light on why Doc's thinking has changed. First, he said that he's...

  • DBMD

    Thanks for the time and thanks to the gang that were there, though cut off from their comments by Erhlich. Regarding Pru...

  • sogiam

    CTIX- Cellceutix Provides Insights to its Four Clinical Trials for the Treatment of ABSSSI (Completed Phase 2), Anti-Can...

  • sogiam

    CTIX- BEVERLY, MA--(Marketwired - August 6, 2015) - Cellceutix Corporation (OTC: CTIX) (the "Company"), a clinical stage...

  • Avatar

    $CTIX......Prurisol trial commences......Dr. Alexander resigns due to health concerns Cellceutix Commenc...

  • Avatar

    $ RCPT: Kenny G you may just get your wish: A Counter Offer For Receptos Inc From Another Bidder Is Possible: Wed...

  • Avatar

    It’s a Novartis world – everybody else just lives in it Source EP Vantage Company Novartis, Actavis, AstraZeneca...

  • Avatar

    Very Interesting. Thanks for That. Having read this article in its entirety I have the following comments: May also h...

  • sogiam

    CTIX- News this a.m. - BEVERLY, MA--(Marketwired - June 08, 2015) - Cellceutix Corporation (OTC: CTIX) (the "Company")...

  • Avatar

    Thanks for sharing. I have psoriasis and this is good to know. I always suspected there were dietary causes (at least in...

  • sogiam

    Psoriasis- Who is NOT chasing this disease? http://www.researchandmarkets.com/research/6v7xbn/psoriasis Best2ALL!-Ben...

  • Avatar

    My late father-in law had Psoriasis, the symptom of which was loss of skin from his head, arms and upper body. The condi...

  • Avatar

    People interested in a variety of treatments for Psoriasis can learn about a promising new drug under clinical study rig...

  • Avatar

    I have both psoriasis and psoriatic arthritis, a bad case of it.. It just happened to me at about 33 years old, I am 42...

  • Avatar

    I had psoriasis from age 7 and intermittently until ~8 years ago. I am 62 years old, 6'2" and 175#, active male. 8 yea...

  • Dr. KSS, MD PhD

    Is Merck out in front in psoriasis race? http://www.nature.com/nature/journal/v521/n7551/full/nature14175.html#affil-...

  • DBMD

    Hendrix regarding ANAC: I reviewed the website and they do have a lot of other investigational drugs for undertreated d...

  • Avatar

    478.Prothena $PRTA At least six companies are targeting Parkinson's, most preclinical. Two, Amicus ($FOLD - pre-clini...

  • Avatar

    $ PRTA $ DYAX $ ESPR Before you said WHOA !, I checked DYAX and the number three holding at XBI, PROTHENA PRTA. ...

  • Dr. KSS, MD PhD

    Jeff---I am pretty ambivalent. This is a bizarre small molecule that nonspecifically affects a number of inflammatory me...

  • Avatar

    Doc, no need for a full analysis, but do you have any thoughts on the likelihood of positive results fror Can-Fite's Pha...

  • Vijay Panikar

    $CANF Can-Fite BioPharma Ltd.'s CEO Pnina Fishman Interviewed by The Life Sciences Report 9:00a ET March 5, 2015 (Ma...

  • sogiam

    CNDO-its plans to use gut parasites to treat psoriasis and autism are not grounded in reality DBMD – the shortcut to t...

  • Dr. KSS, MD PhD

    Vascular Biologics $VBLT cratering 46 percent in pre-market. Its "lecinoxoids" for UC and psoriasis, which reek of BS, p...

  • Avatar

    Re the Dungeon spreadsheet: In my finite way of infinite thinking, there should have been levels of incarceration. ...

  • Avatar

    I'm totally lost. We need to straighten out this thread somehow. I'll post here since I don't know where else to do it....

  • Avatar

    AUPH -- From Scottrade: - "Aurinia Pharmaceuticals Inc., formerly Isotechnika Pharma Inc., is an international biopharm...

  • Avatar

    Virtual presence @ SFO Biotech of Cellceutix presentation Cellceutix Invites All to Attend Company’s Live Webca...

  • Avatar

    Few positive data points for NVS in the recent past Novartis' Cosentyx Approved in Japan for Psoriatic Arthritis yester...

  • Avatar

    Few positive data points for NVS in the recent past Novartis' Cosentyx Approved in Japan for Psoriatic Arthritis yester...

  • Dr. KSS, MD PhD

    Yes Michael Yee of RBC talking with Melissa Lee. We discussed this somewhere here recently. It all depends on what one "...

  • sogiam

    CNDO-Another one to feed our dragons Hi Pockets ha- From TLOGlolytes post 157- To Ben/sogiam: I think you were asking o...

  • Dr. KSS, MD PhD

    To Ben/sogiam: I think you were asking on another thread about Coronado Biosciences $CNDO. This company has a strongly p...

  • Dr. KSS, MD PhD

    Last night we were discussing a new fumaric acid product, similar in some ways to Tecfidera, that might be used against ...

  • Avatar

    Thanks Doc; I probably wasn't clear. They are in Phase 2 for psoriasis using XP23829; not clear who the competition is....

  • Dr. KSS, MD PhD

    Yes...it;s likely to work for MS, but may face patent issues in addition to the fact that, hey, what will it face for co...

  • Avatar

    I haven't seen this one mentioned but it looks potentially interesting. Xenoport ($XENO) actually had positive net inc...

  • Dr. KSS, MD PhD

    Thanks Ben...well this is very good news indeed. Glad you found it. This is an oral agent where, based on mechanism of a...

  • sogiam

    CTIX-Cellceutix: Prurisol(TM) for Psoriasis -- FDA Agrees That Phase 2 Study May Begin 7:40a ET December 10, 2014 (Mark...

  • Dr. KSS, MD PhD

    I think people need to realize that if Prurisol works, given the mechanism, that it will totally topple a dozen psoriasi...

  • Dr. KSS, MD PhD

    Glenn: Can Fite is worth a look. I suspect its CF101 will succeed in psoriasis phase 3, though to really get a feel f...

  • Avatar

    One I find interesting and has a lot of catalysts coming up especially their CF-102 drug for psoriasis and rheumatoid ar...

  • Avatar

    Doc Kss, do you think Can-fite drug for Psoriasis CF101 has a good shot to get past phase 3? I like CTIX Prurisol if the...

  • Avatar

    From the headlines, I thought the stock was Antares Pharma (ATRS), but then as I read the clues, figured it it wasn't. ...

  • Dr. KSS, MD PhD

    Thanks Patrick. I presume this is to provide funding for brilacidin phase 3 skin infections and for Prurisol phase 2 pso...

  • Dr. KSS, MD PhD

    Recent IPO Dermira ($DERM) is getting lots of analyst attention today. This is a company that has made a deal with UCB (...

  • Michael Jorrin (aka Doc Gumshoe)

    Actually, I did mention off-label use, in the section about biosimilars perhaps being better than the original. And, y...

  • Avatar

    Please note that psoriasis causes psoriatic arthritis, and not RA....

  • Dr. KSS, MD PhD

    Sharon: I think you make a fine point, which is that physicians treating lipids in people with other conditions, such as...

  • Dr. KSS, MD PhD

    $CELG's apremilast has some promise for it, though that promise is totally dwarfed by CTIX's Prurisol. That a PDE inhibi...

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

    Connect with Travis

    website designed by Gravity Switch